Atara Biotherapeutics: Q2 Earnings Insights

Atara Biotherapeutics ATRA reported its Q2 earnings results on Monday, August 8, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

Atara Biotherapeutics reported an EPS of $-0.31.

Revenue was up $47.71 million from the same period last year.

Last quarter the company beat on EPS by $0.11 which was followed by a 1.47% increase in the share price the next day.

Here's a look at Atara Biotherapeutics's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-0.98	-0.69	-0.94	-0.89
EPS Actual	-0.87	-0.96	-0.90	-0.91
Revenue Estimate	4.91M	35.14M	3.92M	3.84M
Revenue Actual	7.31M	7.55M	5.37M	3.87M

To track all earnings releases for Atara Biotherapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar